ARK Investment Management’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
ACM
KGAMU
JCM
ARK Investment Management's CDLX Position: Q3 2022 in Review
ARK Investment Management sold out of Cardlytics (CDLX) in Q3 2022, closing a stake of 309 shares — an estimated $80K sold.
ARK Investment Management first reported a position in CDLX in Q4 2021 and held it in 3 quarters. The position peaked at $191K in Q4 2021. 132 funds tracked by Wall St. Rank hold CDLX as of Q3 2022.
- ARK Investment Management reported no remaining Cardlytics position as of Q3 2022 after selling out during the quarter.
- ARK Investment Management sold 309 Cardlytics shares in Q3 2022, an estimated $80K.
- ARK Investment Management first reported a position in Cardlytics in Q4 2021 and held it in 3 quarters.
- ARK Investment Management's Cardlytics position peaked at $191K in Q4 2021.
- 132 funds tracked by Wall St. Rank held Cardlytics as of Q3 2022.
Based on ARK Investment Management's 13F filing for Q3 2022, filed 17 Oct 2022.